1. Home
  2. CUE vs MVO Comparison

CUE vs MVO Comparison

Compare CUE & MVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • MVO
  • Stock Information
  • Founded
  • CUE 2014
  • MVO 2006
  • Country
  • CUE United States
  • MVO United States
  • Employees
  • CUE N/A
  • MVO N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • MVO Oil & Gas Production
  • Sector
  • CUE Health Care
  • MVO Energy
  • Exchange
  • CUE Nasdaq
  • MVO Nasdaq
  • Market Cap
  • CUE 61.1M
  • MVO 49.9M
  • IPO Year
  • CUE 2018
  • MVO N/A
  • Fundamental
  • Price
  • CUE $0.56
  • MVO $1.05
  • Analyst Decision
  • CUE Strong Buy
  • MVO
  • Analyst Count
  • CUE 2
  • MVO 0
  • Target Price
  • CUE $3.00
  • MVO N/A
  • AVG Volume (30 Days)
  • CUE 394.8K
  • MVO 55.1K
  • Earning Date
  • CUE 11-12-2025
  • MVO 01-01-0001
  • Dividend Yield
  • CUE N/A
  • MVO 17.46%
  • EPS Growth
  • CUE N/A
  • MVO N/A
  • EPS
  • CUE N/A
  • MVO 1.46
  • Revenue
  • CUE $7,100,000.00
  • MVO N/A
  • Revenue This Year
  • CUE N/A
  • MVO N/A
  • Revenue Next Year
  • CUE N/A
  • MVO N/A
  • P/E Ratio
  • CUE N/A
  • MVO $7.29
  • Revenue Growth
  • CUE N/A
  • MVO N/A
  • 52 Week Low
  • CUE $0.54
  • MVO $8.85
  • 52 Week High
  • CUE $1.75
  • MVO $13.95
  • Technical
  • Relative Strength Index (RSI)
  • CUE 28.56
  • MVO 5.35
  • Support Level
  • CUE $0.57
  • MVO $4.21
  • Resistance Level
  • CUE $0.62
  • MVO $4.50
  • Average True Range (ATR)
  • CUE 0.08
  • MVO 0.37
  • MACD
  • CUE -0.01
  • MVO -0.35
  • Stochastic Oscillator
  • CUE 0.53
  • MVO 1.02

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About MVO MV Oil Trust Units of Beneficial Interests

MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.

Share on Social Networks: